Related Experiment Videos
Ciamexone--a new highly selective immunosuppressive compound
Journal of Immunopharmacology
|January 1, 1985
Summary
Differences in the major histocompatibility complex (MHC) class II products induce graft-versus-host reactions in mice. Specific drug treatments selectively modulate these immune responses, offering potential therapeutic insights.
Area of Science:
- Immunology
- Transplantation immunology
- Histocompatibility
Background:
- A local graft-versus-host (GvH) reaction can be induced between Balb-c mouse lymphocytes and their F-1 generation (CB6F1).
- This reaction is attributed to differences in the class II major histocompatibility complex (MHC) products, also known as immune response (Ir) genes.
- The local mixed lymphocyte reaction primarily involves T-helper cells and B-cells.
Purpose of the Study:
- To investigate the modulation of local graft-versus-host reactions.
- To explore the effects of specific immunosuppressive agents on GvH reactions and delayed type hypersensitivity (DTH).
Main Methods:
- Induction of a local graft-versus-host reaction in a mouse model.
- Administration of oxazolone to induce delayed type hypersensitivity.
- Treatment with Cyclosporin A and Ciamexone, a 2-cyanaziridine derivative.
Main Results:
- Induction of delayed type hypersensitivity with oxazolone significantly decreased the local GvH reaction.
- Cyclosporin A suppressed both the local GvH reaction and DTH.
- Ciamexone selectively suppressed the local GvH reaction while increasing DTH.
Conclusions:
- Major histocompatibility complex class II differences are key in inducing GvH reactions.
- Drug-induced modulation of immune responses can be selective.
- Ciamexone demonstrates a unique ability to suppress GvH reactions while enhancing DTH.